| Ticker | DICE |
|---|---|
| ISIN | US23345J1043 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target imp...
El precio actual de DICE Therapeutics, Inc. (DICE) es de 47,55 , con una variación del 0,06%.
DICE Therapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.